Half a decade of planning and millions of dollars have culminated in the Alliance for Cardiovascular Diagnostic and Treatment Innovation (ADVANCE), a joint engineering and cardiology center launched by Johns Hopkins University in an…

Even after adjusting for cardiovascular, behavioral and socioeconomic factors, black adults remain twice as likely to die from sudden cardiac death (SCD) as whites, suggests a study…

There were no serious adverse events related to competition in a study of 129 young athletes with implantable cardioverter defibrillators (ICDs), providing reassurance that moderate-to-intense physical activity in this population may be…

Individuals with clinical depression could face a more than seven-fold increased risk of atrial fibrillation (AF), especially in the earliest stages of their diagnosis, a population…

A decades-long study of patients who have migraines with visual aura has linked the painful headaches to an increased risk of experiencing atrial fibrillation and, to a lesser degree, stroke, researchers report in the online…

When approached again, about a quarter of patients with atrial fibrillation (AFib) not taking anticoagulants due to physician-cited “patient refusal” said they would consider taking the drugs, according to preliminary research presented at…

For patients with nonvalvular atrial fibrillation (AFib), taking a direct oral anticoagulant (DOAC) instead of warfarin may cut the risk of dementia by 15 to 20 percent, according to a large database…

The American College of Cardiology, American Heart Association and Heart Rhythm Society on Nov. 6 released a new guideline for the evaluation and treatment of patients with bradycardia and cardiac conduction disorders.

…

A Stanford- and Apple-led atrial fibrillation study of more than 400,000 U.S. residents—the largest AFib screening effort to date—has entered its final phase of data collection, the company announced Nov. 1. The trial is expected to…

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

Blake has spent the past 16 years as the CEO of the American Society for Gastrointestinal Endoscopy…

Higher ejection fractions (EFs) among heart failure patients are associated with an increased incidence of atrial fibrillation (AF) and worse cardiovascular outcomes, according to data from a multinational European registry.

Barak Zafrir…

Medtronic co-founder Earl Bakken, who invented the world’s first wearable, battery-powered pacemaker, died on Oct. 21 in his Hawaii home, the company…

Officials in Clark County, Indiana, are urging locals to download a new phone app that would alert CPR-certified individuals to cardiac arrests happening nearby. An accompanying app also maps out the county’s nearest AEDs, or automated external…

Clinically significant arrhythmias are rare during exercise stress tests (ESTs) in pediatric heart patients, researchers reported in…

Catheter ablation was associated with better arrhythmia-free survival and lower complication rates than surgical ablation in patients with paroxysmal or early-onset persistent atrial fibrillation (AFib), according to a small, randomized…

A team at Purdue University in West Lafayette, Indiana, this week announced progress on its latest cardiology wearable: a plant-based, stretchable wrist sticker that has the ability to monitor physical activity and alert users to health risks in…

Harvard Medical School scientists have created a wirelessly programmed, miniaturized pacemaker which functions for weeks to months at a time, opening the door to “previously impossible investigations of arrhythmia and heart failure in the…

Preliminary results from the RETAKO trial, a study of takotsubo syndrome (TTS) in the Spanish population, have identified cardiogenic shock (CS) as an independent, strong predictor of mortality and complexities in TTS patients—a demographic that’…

Direct oral anticoagulants (DOACs) can cut the short-term risk of thromboembolic events in half for patients who have undergone cardioversion of atrial fibrillation (AFib), suggests a …

When cardiologists get involved in the treatment of patients with a history of cancer and newly diagnosed atrial fibrillation (AFib), those people see a subsequent 11 percent reduction in the risk of stroke, according to a new…

Digoxin, a cardiac glycoside popularly sold under the brand name Lanoxin, poses a major threat to the heart health of atrial fibrillation (AF) and heart failure (HF) patients, according to a…